Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: November 29, 2009
Rituximab May Offer Hope To Severe Graves' Eye Disease Patients
November 29, 2009There may be hope for patients with severe Graves' eye disease in the form of treatment with the drug rituximab.
This news comes from U-M Kellogg Eye Center who's oculoplastics specialist Raymond S. Douglas, M.D., Ph.D. reports on the potential of the drug in the online October issue of Ophthalmology.
Graves' eye disease is an autoimmune disease that causes inflammation and fatty deposits in the eye muscles and connective tissue surrounding the eye.
Douglas reports on the progress of six patients (four women, two men) who had not responded to treatment using systemic corticosteroids. The patients were then treated with rituximab. All patients responded within 2 months with the clinical activity score (CAS) improving from5.5±0.8 to 1.3±0.5. The eye disease remained quiescent in all with the positive results being sustained at 4-6 months after treatment.
Vision improved bilaterally in all 4 patients with dysthyroid optic neuropathy (DON). Proptosis remained stable (Hertel measurement, 24±3.7 mm before therapy and 23.6±3.7 mm after therapy; P = 0.17).
"These patients had already received the maximum level of steroid treatment," says Douglas. "Treatment with rituximab calmed inflammation, stopped progression of the disease, and saved the patients from having to undergo surgery."
Graves' disease (also known as thyroid eye disease) is an autoimmune condition in which white blood cells attack the thyroid gland which responds by secreting an excess amount of thyroid hormone. The hypermetabolic state is characterized by fast pulse/heartbeat, palpitations, profuse sweating, high blood pressure, irritability, fatigue, weight loss, heat intolerance, and loss of hair and alterations in hair quality.
Rituximab has been used to treat patients with other autoimmune diseases, including rheumatoid arthritis and in non-Hodgkin's B-cell lymphoma. The drug works by depleting B cells - the body's normal antibody-producing cells - that appear to go awry in autoimmune diseases.
"Treatment of the inflammatory component of Graves' eye disease has not advanced appreciably over several decades," says Douglas. High-dose steroids, sometimes in combination with orbital radiation, are still the first line treatment. But, says Douglas, "These are imperfect options because inflammation often recurs when the treatment ends." He is hopeful that rituximab can offer sustained improvement. Douglas observes that the results from a small case series must be viewed with some caution. But given the substantial benefits for patients treated with rituximab, he sees good reason to proceed with a large-scale clinical trial to test this promising new drug.
Source
Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy; Ophthalmology, 2009; Chong et al.; DOI: 10.1016/j.ophtha.2009.05.029
University of Michigan Health System Newsroom
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15 16 17
November 20, 2009 | Yes, Cats Can Catch the Swine FluOur cut little and cuddly cats that purr at us and give us so much love seems be susceptible to catch the swine flu. In fact, a cat in Iowa has tested positive for the H1N1 virus, state officials confirmed this morning, "marking the first time a cat has been diagnosed with this strain of influenza," the association said in a statement. "The cat, which has recovered, is believed to have caught the virus from someone in the household who was sick with H1N1. ...
November 19, 2009 | Embryonic Stem Cells May Be Used To Create New SkinBoston (SmartAboutHealth) - A new study out of France has revealed that embryonic stem cells may be used to actually create new skin for humans. The belief is that by using these embryonic stem cells to create new skin, that it could prove extremely helpful in the treatment of burn victims. Burn victims ...
November 18, 2009 | Back Pain Linked To Everyday ActivitesWhile that occasional back pain may go away after some rest and pain medication, many back pain sufferers are not aware that everyday activities - from wearing high heels to long work hours - can repeatedly strain the spine may lead to more serious consequences later. According to White Plains based neurosurgeon Dr. Jack Stern, M.D., Ph.D., some activities that repeatedly strain the spine may eventually lead ...
Related articles:
Chronic prostatitis/chronic pelvic pain syndrome - pharmacological treatment
There is a substantial list of medications used to treat this disorder. Some of them are: Quercetin has shown effective in a randomized, placebo-controlled trial in chronic prostatitis using 500 mg twice a day for 4 weeks Subsequent studies showed that quercetin, a mast cell inhibitor, reduces inflammation and oxidative stress in the ...Section: Prostatitis
Risk-taking - media encouragement
According to Arran Stibbe, men's health problems and behaviors can be linked to the socialized gender role of men in our culture. In exploring magazines, he found that they promote traditional masculinity. The magazine celebrates "male" things such as liking guns, fast cars, and fast women and reading pornography regularly. In the magazine several "ideal" ...Section: Mens health risks
Chronic bacterial prostatitis - diagnosis
In chronic bacterial prostatitis there are bacteria in the prostate but usually no symptoms. The prostate infection is diagnosed by culturing urine as well as prostate fluid (expressed prostatic secretions or EPS) which are obtained by the doctor doing a rectal exam and putting pressure on the prostate. If no fluid is recovered after this prostatic massage, a post massage urine should also contain any prostatic bacteria. Prostate specific antigen levels may be elevated, although there is no malignancy. Semen ...Section: Prostatitis